Motegrity

Prucalopride

Developed to target chronic constipation where laxatives fail, this medication is utilized to support bowel regularity and to alleviate intestinal discomfort.

Active ingredient
Prucalopride
Supply
Pharmacy
Route
Oral use
Form
Film-coated tablet
Strengths
2mg

Motegrity details

Alternative names
Resolor
Therapeutic class
Serotonin (5-HT4) Receptor Agonist
Pharmacological class
5-HT4 Agonist
Precautions and warnings
monitor for severe diarrhoea; use caution in cardiac patients
Minor side effects
headache; nausea; diarrhoea; abdominal pain
Moderate side effects
dizziness; flatulence; fatigue
Dosage forms
Film-coated tablet
Administration route
Oral use
Supply category
Pharmacist only, dispensed without a prescription
Manufacturer
Shire
Onset Time
1–2 hours
Duration
24 hours
Storage instructions
Store in a cool, dry place.
Drug interactions
atropine; erythromycin
Age restrictions
Not for use in children under 18.
Pregnancy and breastfeeding
Pregnancy: Not recommended. Breastfeeding: Not recommended.
Contraindications

hypersensitivity; severe renal impairment; intestinal perforation; severe inflammatory diseases of the intestinal tract

Serious side effects

tachycardia, requires immediate medical attention; palpitations, requires immediate medical attention

Patient summary

Developed to target chronic constipation where laxatives fail, this medication is utilized to support bowel regularity and to alleviate intestinal discomfort.

Mechanism of action

Prucalopride is a high-affinity 5-HT4 receptor agonist that stimulates colonic motility, thereby increasing bowel movement frequency and reducing the symptoms of chronic constipation.

Where this medicine is registered

  • Singapore
  • Hong Kong
  • Thailand
  • Malaysia
  • Philippines
  • Indonesia
  • Taiwan
  • South Korea
  • Japan
  • Australia
  • New Zealand
  • UAE
  • South Africa

About Motegrity

Motegrity is a medication containing prucalopride, used to manage chronic constipation in adults when standard laxatives fail to provide relief. The same active ingredient is known globally as Resolor, produced by Shire and supplied as 2mg tablets. Consistent use supports regular bowel function for those struggling with long-term digestive motility issues.

Buying Motegrity online

Motegrity is registered across 13 markets including Japan, the UAE and Singapore, with availability extending to Hong Kong, Thailand and Malaysia. As a targeted treatment for digestive health, the medication is frequently ordered online for delivery across the region. Expats and residents who require consistent access to their established regimen often find that online procurement provides a reliable way to maintain their treatment cycle without the uncertainty of local pharmacy stock levels.